PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.60M | 21.66M | 26.71M | 26.20M | 31.87M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.45M | 1.23M | 1.54M | 1.69M | 1.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.05M | 22.89M | 28.25M | 27.89M | 33.65M |
|
|
|||||
| Total Current Assets | 7.05M | 22.89M | 28.25M | 27.89M | 33.65M |
| Net Property, Plant & Equipment | 213.40K | 228.60K | 243.70K | 258.80K | 274.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.55M | 1.55M | 2.00M | 6.55M | 6.55M |
| Total Assets | 8.81M | 24.66M | 30.49M | 34.71M | 40.48M |
|
|
|||||
| Total Accounts Payable | 6.39M | 3.65M | 3.57M | 5.18M | 4.50M |
| Total Accrued Expenses | 1.63M | 1.26M | 742.20K | 2.10M | 1.48M |
| Short-term Debt | -- | 5.21M | 5.13M | 6.00M | 5.50M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.35M | 31.00K | 36.20K | 44.10K | 51.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.38M | 10.15M | 9.48M | 13.33M | 11.53M |
|
|
|||||
| Total Current Liabilities | 12.38M | 10.15M | 9.48M | 13.33M | 11.53M |
| Long-Term Debt | -- | 10.61M | 11.73M | 11.89M | 12.94M |
| Short-term Debt | -- | 5.21M | 5.13M | 6.00M | 5.50M |
| Capital Leases | 9.50K | 17.70K | 25.70K | 33.50K | 41.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.39M | 20.77M | 21.24M | 25.25M | 24.52M |
|
|
|||||
| Common Stock & APIC | 230.13M | 227.85M | 225.86M | 218.50M | 215.99M |
| Retained Earnings | -233.71M | -223.96M | -216.61M | -209.04M | -200.03M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.58M | 3.89M | 9.25M | 9.45M | 15.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.58M | 3.89M | 9.25M | 9.45M | 15.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.58M | 3.89M | 9.25M | 9.45M | 15.96M |
|
|
|||||